Trending Medical and well being breaking information Myeloid Sufferers Reply Robustly to Moderna COVID Vaccine
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Nearly every patient with a myeloid malignancy seroconverted against COVID-19 after their second dose of the Moderna vaccine in a review of 46 patients at the Moffitt Cancer Center in Tampa, Fla. Factors including age, gender, race, disease status, lower-intensity active…